Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886).
(Q37803366)
scientific article published on 27 October 2010
scientific article published on 27 October 2010
Language:
Current Data About
Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886).